The National Advertising Division (NAD) opened an inquiry regarding Provezza Health’s (New York City, NY) elderberry syrup after the firm featured an Instagram post that read, “Potent Immune Support During A Severe Season. Provezza is highly concentrated to deliver antioxidant action for immune defense.”
Provezza Health informed NAD that the post was permanently discontinued prior to the inquiry, and though the firm disagreed that the post implied it can protect consumers against the Coronavirus, it said Provezza would refrain from making express or implied claims with a similar message moving forward.
NAD shares the Federal Trade Commission (FTC) and FDA’s concerns regarding supplement manufacturers touting that their products can cure or increase consumers’ immunity to protect them from COVID-19. It is using its monitoring resources to seek out product claims that are misleading with health-conferring benefits related to COVID-19.
According to a press release, Provezza Health thanked NAD for “its ongoing monitoring efforts of the dietary supplement industry” and stated that it has “never expressly or impliedly claimed to treat COVID-19 or any other disease, and we will continue this policy into the future.”
Social media post from Provezza Health draws unwanted attention from NAD
The National Advertising Division (NAD) claims that Provezza Health's Instagram post made illegal COVID-19 claims.
Photo © iStockphoto.com/s-cphoto
The National Advertising Division (NAD) opened an inquiry regarding Provezza Health’s (New York City, NY) elderberry syrup after the firm featured an Instagram post that read, “Potent Immune Support During A Severe Season. Provezza is highly concentrated to deliver antioxidant action for immune defense.”
Provezza Health informed NAD that the post was permanently discontinued prior to the inquiry, and though the firm disagreed that the post implied it can protect consumers against the Coronavirus, it said Provezza would refrain from making express or implied claims with a similar message moving forward.
NAD shares the Federal Trade Commission (FTC) and FDA’s concerns regarding supplement manufacturers touting that their products can cure or increase consumers’ immunity to protect them from COVID-19. It is using its monitoring resources to seek out product claims that are misleading with health-conferring benefits related to COVID-19.
According to a press release, Provezza Health thanked NAD for “its ongoing monitoring efforts of the dietary supplement industry” and stated that it has “never expressly or impliedly claimed to treat COVID-19 or any other disease, and we will continue this policy into the future.”
CRN adopts new voluntary guidelines on melatonin and gummy supplements
April 18th 2024The first set of guidelines are for the formulation, labeling, and packaging of melatonin-containing supplements, and the second is relates to the labeling of gummy dietary supplements.
Beverage contract manufacturing: what’s new and what’s expected
April 18th 2024What goes into creating successful functional beverages?
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
The lactoferrin market: A conversation with Helaina at SupplySide East 2024
April 17th 2024Nutritional Outlook sits down with Helaina's COO, Paola Delgado, to talk about the lactoferrin market.
Joint health customers are getting younger
April 17th 2024Millennials are reaching middle age and want to protect their joints so they can stay active for longer.
Immune health still matters
April 17th 2024The immune health category remains relevant and thriving.
CRN adopts new voluntary guidelines on melatonin and gummy supplements
April 18th 2024The first set of guidelines are for the formulation, labeling, and packaging of melatonin-containing supplements, and the second is relates to the labeling of gummy dietary supplements.
Beverage contract manufacturing: what’s new and what’s expected
April 18th 2024What goes into creating successful functional beverages?
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
The lactoferrin market: A conversation with Helaina at SupplySide East 2024
April 17th 2024Nutritional Outlook sits down with Helaina's COO, Paola Delgado, to talk about the lactoferrin market.
Joint health customers are getting younger
April 17th 2024Millennials are reaching middle age and want to protect their joints so they can stay active for longer.
Immune health still matters
April 17th 2024The immune health category remains relevant and thriving.